Hydrolase Enzymes Market to Reach $13.4 Billion by 2034 at 7.5% CAGR Driven by Enzymatic Fat Splitting, Dairy Innovation, and Industrial Biosolutions
The Hydrolase Enzymes Market is projected to grow from $7 billion in 2025 to $13.4 billion by 2034, registering a CAGR of 7.5%. Expansion is fueled by rising demand for proteases, lipases, amylases, lactases, and cellulases across food processing, animal nutrition, home care detergents, bioindustrial applications, and sustainable oleochemical production. The market is increasingly shaped by consolidation among global enzyme leaders, vertical integration in feed enzymes, and strong R&D pipelines targeting plant-based foods, low-temperature processing, and energy-efficient industrial biocatalysis.
In January 2024, the merger between Novozymes and Chr. Hansen was completed, creating Novonesis, a $12.3 billion biosolutions leader with one of the most comprehensive hydrolase enzyme portfolios globally. The integration strengthened capabilities in food, beverage, and planetary health biosolutions, consolidating advanced fermentation platforms and application expertise under a unified structure. In the same month, Kerry Group finalized the €150 million acquisition of the global lactase enzyme business divested as part of the merger conditions, reinforcing its position in lactose-free dairy and sugar-reduced formulations. In June 2024, BASF divested its bioenergy enzyme business and Spartec portfolio to Lallemand, sharpening its focus on hydrolases for animal nutrition and detergent applications. In late 2024, AB Enzymes and APC Group formed a strategic alliance to expand hydrolase distribution in Asia and the Middle East, targeting pulp, paper, and textile processing industries undergoing rapid industrial expansion.
Momentum intensified in 2025 with vertical integration and product innovation shaping competitive dynamics. In February 2025, Novonesis acquired dsm-firmenich’s stake in their Feed Enzyme Alliance for $1.6 billion, integrating hydrolase production for animal nutrition directly into its global commercial network. In March 2025, dsm-firmenich launched Maxiren® EVO, an advanced chymosin protease designed to enhance cheese yield and texture consistency across varying milk qualities. In February 2025, Novonesis reported launching 45 new innovations during its first operational year, with hydrolase-based household care products contributing to 13% organic growth in 2024. In October 2025, dsm-firmenich inaugurated its Global Food Innovation Center in Delft, dedicated to advancing plant-based protein texturization using tailored hydrolases. That same month, BASF and IFF entered a strategic enzyme collaboration focused on Designed Enzymatic Biomaterials™, targeting high-performance hydrolases for home care, personal care, and industrial cleaning segments by 2026. In November 2025, Novonesis and thyssenkrupp Uhde introduced an enzymatic fat-splitting process utilizing Lipura Split lipase, enabling oleochemical production at 70°C and atmospheric pressure instead of traditional 260°C and 60 bar systems, reducing energy consumption by nearly 90%.
Strategic restructuring continued into 2026 as portfolio focus sharpened across the enzyme landscape. In February 2026, dsm-firmenich agreed to divest its Animal Nutrition & Health business to CVC Capital Partners for €2.2 billion, signaling a transition toward consumer-focused nutrition and beauty solutions. In February 2026, IFF announced the sale process for its Food Ingredients segment to prioritize its Health & Biosciences division, which recorded 7% EBITDA growth driven by specialty enzyme volumes. The hydrolase enzymes market is increasingly defined by fermentation technology scaling, precision enzyme engineering, low-energy biocatalysis, clean label dairy processing, plant-based protein optimization, and vertically integrated feed enzyme platforms serving global food, feed, and industrial biotechnology markets.
Hydrolase Enzymes Market Trends and Opportunities
Multi-Enzyme Systems Enabling Low-Temperature, Low-Carbon Cleaning Performance
The hydrolase enzymes market is shifting decisively from single-enzyme formulations toward integrated multi-enzyme systems engineered to deliver performance, sustainability, and fabric care simultaneously. Leading consumer packaged goods manufacturers are increasingly formulating detergent platforms that combine proteases, amylases, lipases, and mannanases to target complex, mixed-origin stains under cold and short-cycle wash conditions. This transition directly addresses lifecycle emissions, as the consumer use phase accounts for more than 60% of the total carbon footprint of household detergents.
A critical inflection point occurred during 2024 and 2025 with the commercialization of next-generation proteases capable of maintaining structural stability in liquid formulations without chemical stabilizers. International Flavors & Fragrances introduced PREFERENZ® P 400, a laundry protease engineered to retain high catalytic activity at wash temperatures as low as 30°C. This innovation allows formulators to meet tightening sustainability benchmarks while maintaining premium cleaning claims in liquid detergents.
Consumer behavior change is reinforcing this trend at scale. Procter & Gamble continues to expand its #TurnToCold initiative through 2025, targeting a shift where approximately 75% of global laundry loads are washed in cold water. Supported by advanced hydrolase blends, cold-water washing can reduce per-load energy consumption by up to 90%, translating into meaningful household energy savings and extended garment life. In parallel, the automatic dishwashing segment is adopting enzyme systems designed for short, eco-labeled cycles. Late-2024 launches of targeted proteases for protein-dense soils such as egg residues address a key consumer barrier to low-temperature dishwashing, further accelerating enzyme penetration in sustainable home care.
Capital Deployment into Cellulase Platforms for Second-Generation Biofuels and SAF
The hydrolase enzymes market is also being reshaped by large-scale investments in second-generation biofuels and Sustainable Aviation Fuel, where cellulases and hemicellulases act as critical enablers for converting lignocellulosic biomass into fermentable sugars. Unlike first-generation starch-based pathways, these technologies rely on enzymatic hydrolysis to unlock value from agricultural residues, positioning hydrolase enzymes as strategic infrastructure components rather than consumables.
Public and private capital alignment has accelerated commercialization. In fiscal year 2025, the U.S. Department of Energy committed $35 million under the CLIMR program, leveraged to over $57 million with private funding, to advance enzymatic conversion routes for high-energy-density SAF blendstocks. These programs emphasize the integration of advanced cellulase cocktails with optimized pre-treatment processes, enabling higher sugar yields from corn stover, wheat straw, and distillers grains.
Strategic consolidation within the enzyme industry further underscores the long-term growth outlook. In February 2025, Novonesis completed the acquisition of dsm-firmenich’s stake in their Feed Enzyme Alliance, creating a vertically integrated biosolutions platform spanning hydrolases, probiotics, and fermentation expertise. By 2025, process optimization and enzyme engineering advances were delivering efficiency gains of up to 20% in cellulosic ethanol production, materially narrowing the cost gap between second-generation and conventional biofuels.
Precision Lipase Applications in Infant Nutrition and Advanced Lipid Engineering
High-selectivity lipases represent one of the most attractive value pools in the hydrolase enzymes market, particularly within infant formula, medical nutrition, and functional lipid applications. These markets prioritize molecular precision over volume, allowing enzyme suppliers to command premium pricing for tailored biocatalysts.
In early-life nutrition, manufacturers are increasingly using lipases to synthesize structured triglycerides that replicate the positional fatty acid distribution of human milk. Enzymatic production of OPO and SN-2 palmitate lipids enhances calcium absorption and digestive tolerance, narrowing the functional gap between infant formula and breast milk. Kerry Group and dsm-firmenich expanded their early-life portfolios in 2025, reflecting sustained demand from premium formula producers.
A parallel opportunity exists in algal-based omega-3 production. Enzymatic extraction using hydrolases enables solvent-free lipid recovery under mild conditions, delivering contaminant-free DHA and EPA suitable for infant and clinical nutrition. dsm-firmenich’s life’s® portfolio illustrates how hydrolase-enabled processes support plant-based positioning while meeting stringent purity standards. Beyond infant nutrition, personalized metabolic health is driving demand for lipases capable of selectively enriching omega-3 fractions, supporting the growing proactive health and supplementation market.
Thermostable Hydrolases as Green Catalysts for Pharmaceutical Manufacturing
Biocatalysis is emerging as a core pillar of pharmaceutical process innovation, creating a structural opportunity for thermostable hydrolases in Active Pharmaceutical Ingredient synthesis. Under mounting regulatory and cost pressure, pharmaceutical manufacturers are replacing metal-based and solvent-intensive chemistries with enzymatic routes that align with green chemistry principles.
Industry case studies published in late 2025 demonstrate that hydrolase-driven synthesis can reduce solvent usage by up to 50% while operating at ambient temperature and pressure. Major pharmaceutical players including GlaxoSmithKline and Merck have expanded licensed biocatalytic processes to improve yield, safety, and scalability. This shift is particularly pronounced in oncology, where single-isomer purity is critical and traditional chemical synthesis often requires multiple protection and deprotection steps.
The rapid expansion of Highly Potent APIs further strengthens this opportunity. By December 2025, HPAPI demand in oncology had increased sharply, favoring aqueous, enzyme-based synthesis routes that minimize operator exposure to hazardous intermediates. As a result, engineered hydrolases are increasingly positioned as first-choice catalysts for complex, chiral molecules, reinforcing their role as strategic assets in pharmaceutical manufacturing rather than auxiliary processing aids.
Hydrolase Enzymes Market Share and Segmentation Insights
Peptidase Enzymes Lead the Hydrolase Enzymes Market Through Multi-Industry Industrial Applications
Peptidases accounted for 38.60% of the Hydrolase Enzymes Market share in 2025, establishing them as the most widely used enzyme category within industrial biotechnology and enzyme processing industries. Peptidases, commonly referred to as proteases, function by hydrolyzing peptide bonds in proteins, enabling protein breakdown into smaller peptides and amino acids. Their versatility has made them indispensable across detergent formulations, food processing, animal nutrition, pharmaceuticals, and biotechnology manufacturing. In the detergent industry, proteases play a crucial role in removing protein-based stains such as blood, food residues, and grass, making them essential components of modern laundry detergents and dishwashing formulations. The 2025 innovation trend centers on enzyme engineering and protein optimization technologies, which have enabled manufacturers to develop advanced protease variants capable of maintaining high catalytic activity in low-temperature washing conditions and concentrated detergent systems. These engineered enzymes also demonstrate improved chemical stability in liquid detergent formulations and compatibility with other enzyme systems, allowing detergent manufacturers to improve cleaning performance while reducing washing temperatures and overall energy consumption.
Food and Beverage Processing Drives the Largest Hydrolase Enzyme Consumption
Food and Beverages represented 34.80% of the Hydrolase Enzymes Market share in 2025, making the sector the largest end-use industry for hydrolase-based enzyme technologies. Hydrolase enzymes including amylases, proteases, lipases, and glycosidases are essential tools in modern food manufacturing processes, enabling controlled biochemical reactions that improve texture, flavor development, digestibility, and processing efficiency. In baking applications, amylases convert starch into fermentable sugars to improve dough fermentation and bread volume, while proteases assist in protein modification and gluten control. Lipases are widely used for flavor development in dairy products and specialty cheeses, while other hydrolases enable targeted hydrolysis reactions in brewing, fruit juice clarification, and starch processing. In 2025, enzyme demand in the food sector is increasingly influenced by the expansion of clean label food formulations, where enzymes function as processing aids that reduce the need for synthetic additives or chemical processing agents. Manufacturers are replacing modified starches, artificial tenderizers, and chemical emulsifiers with enzyme-driven processing technologies, allowing food producers to maintain product quality while meeting evolving consumer expectations for natural ingredients and simplified product labels.
Competitive Landscape in Hydrolase Enzymes Market
Novonesis Consolidates Global Leadership in Industrial Hydrolases
Novonesis, formed through the $12.3 billion merger of Novozymes and Chr. Hansen in 2024, is the dominant global player in industrial hydrolase enzymes. The company targets 6 to 8% organic revenue growth and an EBIT margin near 29% in 2026 as it completes its integration program valued at approximately €250 million. Its portfolio is evenly split between healthier food solutions such as lactases and proteases, and climate-neutral solutions such as cellulases and lipases used in detergents and bio-processing. Novonesis controls one of the industry’s most comprehensive hydrolase portfolios, including Lactozym lactase and leading amylases for grain milling and baking. Synergy-driven R&D expansion strengthens its position in feed enzymes, dairy processing, and sustainable biosolutions.
IFF Expands Enzymatic Biomaterials and Sugar Reduction Platforms
International Flavors & Fragrances has become a major force in enzymatic taste and texture modification following its integration of DuPont Nutrition & Biosciences. In October 2025, IFF announced a collaboration with BASF to accelerate development of Designed Enzymatic Biomaterials for home and personal care applications. The company markets Nurica, a hydrolase that converts lactose into prebiotic fiber directly within dairy matrices, enabling dual sugar reduction and fiber enrichment claims. Its BCLEAR enzymatic solution enhances beer clarity through targeted protein hydrolysis, reducing mechanical filtration requirements. IFF is investing heavily in label-friendly hydrolases that minimize synthetic emulsifier use in bakery and dairy, reinforcing its presence in functional and clean-label food innovation.
Kerry Group Strengthens Functional Nutrition Through Lactase Integration
Kerry Group has expanded aggressively into enzyme biotechnology to support its functional nutrition strategy. The acquisition of a lactase enzyme portfolio in 2024 and 2025 reinforced its leadership in lactose-free dairy applications, a segment experiencing double-digit growth in 2026. Kerry reported €6.8 billion in revenue for 2025, with its Taste & Nutrition division outperforming industry benchmarks by 300 basis points. The company integrates hydrolase production directly into flavor and fragrance systems to offer turnkey clean-label solutions for the global functional food market. Kerry also leads in enzymatic hydrolysis of cream using specialized lipases that intensify natural buttery aromas while reducing ingredient load.
DSM-Firmenich Focuses on High-Margin Hydrolase Applications
DSM-Firmenich continues refining its portfolio toward high-value enzyme and nutrition solutions. In February 2026, the company agreed to divest its Animal Nutrition & Health business for €2.2 billion while retaining a 20% stake to maintain supply continuity. The firm is transitioning toward a consumer-focused innovation model centered on hydrolase-based taste, texture, and nutritional enhancement technologies. Through its Feed Enzymes Alliance with Novonesis, DSM-Firmenich offers a comprehensive protease and phytase portfolio for sustainable livestock production. Its Maxilact lactase and specialized proteases remain widely adopted in lactose-free dairy, pharmaceutical synthesis, and specialty nutrition applications.
BASF SE Advances Bio-Based and Industrial Cleaning Enzyme Systems
BASF is repositioning its Nutrition & Care and Agricultural Solutions divisions to emphasize bio-based hydrolase innovation. In late 2025, BASF initiated a strategic collaboration with IFF to develop next-generation enzyme systems for industrial cleaning, targeting replacement of conventional surfactants with performance hydrolases. The company achieved an annual cost reduction run rate of €1.7 billion by the end of 2025, strengthening capital allocation for biosolutions expansion at its Zhanjiang Verbund site in China. BASF supplies hydrolases across coatings, detergents, and specialty applications, including the Sovermol product line for bio-based coatings. Its enzyme platforms align with energy-efficient laundry formulations and low-temperature washing trends.
Amano Enzyme Targets Clean-Label and Precision Hydrolase Niches
Amano Enzyme Inc. remains a specialized leader in high-purity, non-GMO hydrolases derived from traditional fermentation techniques. In 2025 and 2026, the company scaled production of Protein-Glutaminase Amano 500, an enzyme that enhances plant protein solubility and creaminess without generating bitterness. Amano is targeting personalized nutrition and medical food markets with customized enzyme solutions tailored to sports and clinical formulations. Its Asia-Pacific expansion includes showcasing hydrolases for diagnostic reagents and pharmaceutical processing applications. With more than a century of expertise in fermentation science, Amano maintains global leadership in lipase and amylase precision for gourmet food processing and high-end healthcare applications.
Denmark: Platform Convergence, Electrified Fermentation, and Export-Ready Biosafety
Denmark continues to anchor the global hydrolase enzymes industry through platform integration, energy transition, and regulatory readiness for international markets. The successful merger forming Novonesis consolidated enzyme and microbial capabilities, enabling cross-fertilization across food, health, and nutrition applications. Through 2025, the group reported progress toward its organic growth objectives, underpinned by portfolio rationalization and accelerated commercialization of hydrolase-led solutions. This convergence is strengthening Denmark’s position in lipases, proteases, and carbohydrases tailored for clean-label foods and functional nutrition.
Operational decarbonization is reinforcing competitiveness. In late 2025, Novonesis committed capital to electrify major fermentation lines in Denmark, targeting Scope 1 and 2 net-zero alignment by 2030 while improving yield efficiency in hydrolase production. Regulatory milestones are unlocking export pathways. In March 2024, the company cleared biosafety reviews by China’s MARA for HMO enzyme dossiers, enabling 2025–2026 exports. Innovation at the application edge remains active. In May 2025, Danish research-industry collaborations piloted immobilized lipase systems for high-purity biodiesel, reducing feedstock waste by 12% and demonstrating hydrolases as productivity multipliers in energy-adjacent processes.
India: BioE3 Scale-Up, Biofoundries, and Import Substitution
India’s hydrolase enzymes industry is transitioning from fragmented capacity to coordinated biomanufacturing under national policy. The BioE3 Policy reviewed in July 2025 designated bio-based chemicals and enzymes as a core vertical, attracting more than 2,000 proposals in the first call for biomanufacturing hubs. This surge reflects rising demand for hydrolases in textiles, paper processing, pharmaceuticals, and food preservation, with policy support emphasizing domestic value creation.
Infrastructure for precision development is expanding. The Moolankur BioEnabler Network launched in 2025 established a national grid of biofoundries and Bio-AI hubs to accelerate design-build-test cycles for hydrolases tailored to Indian substrates and operating conditions. Import substitution is advancing in pharma. Gujarat Alkalies and Chemicals Ltd. optimized high-purity enzyme lines in early 2025 to localize pharmaceutical-grade proteases. Delivery models are evolving. By late 2025, roughly 40% of new enzyme projects under DBT-BIRAC joint calls were led through public-private partnerships, signaling a maturing innovation ecosystem that blends startup agility with industrial scale.
China: Enzymatic Mandates, Food Approvals, and Circular Polymers
China’s hydrolase enzymes industry is advancing through regulatory mandates, food system approvals, and circular manufacturing. Under the MIIT’s Green Development Plan concluding the 14th Five-Year period, tanning and textile sectors are transitioning to enzymatic processes to reduce chemical oxygen demand in wastewater, driving adoption of proteases and amylases at industrial scale. Food and beverage applications gained momentum in February 2025 when the National Health Commission approved new food materials, including enzymes derived from genetically modified microorganisms for modulated milk and beverages.
Circular polymers are a parallel growth vector. In January 2025, Sinopec operationalized hydrolase-based chemical recycling for Nylon 6 under the loopamid platform in Shanghai, targeting a 70% carbon footprint reduction versus virgin production. Looking forward, 2026 directives emphasize localization of electronic special chemicals, where ultra-pure enzymes are used for precision cleaning in 12-inch wafer fabrication, extending hydrolase relevance into electronics manufacturing.
United States: R&D Scale, Process Substitution, and Biofuel Enablement
The United States hydrolase enzymes market is characterized by R&D scale-up, regulatory-driven process substitution, and biofuel infrastructure buildout. Following integration of nutrition and biosciences capabilities, International Flavors & Fragrances doubled effective R&D capacity and launched initiatives in animal nutrition enzymes to improve feed efficiency in emerging markets. Trade performance is reinforcing capacity decisions. After the U.S. Department of Agriculture reported record processed food exports in May 2024, U.S. producers expanded amylase and protease lines through 2025 to serve enzyme-modified shelf-stable products.
Environmental regulation is accelerating enzymatic substitution. Stricter VOC standards effective in early 2026 are pushing manufacturers in the Midwest toward biocatalysis in place of solvent-based synthesis. Energy transition funding is expanding demand. In late 2025, the U.S. Department of Energy awarded grants for cellulase-integrated biorefineries converting agricultural residues into sustainable aviation fuel, anchoring hydrolases in next-generation fuels.
Germany: Food Enzyme Excellence and Low-Energy Industrial Pilots
Germany’s hydrolase enzymes industry blends food innovation with industrial decarbonization pilots. In 2025, Kerry Group advanced its Biotechnology Innovation Centre in Leipzig to serve enzyme-led taste and bio-fermentation platforms, reinforcing Germany’s role in high-value food enzymes. Product leadership was recognized when dsm-firmenich received a 2025 R&D award for Maxiren EVO, a pure chymosin hydrolase that improves cheese moisture retention by up to 1.7%.
Beyond food, German clusters are piloting hydrolase integration in methane pyrolysis workflows to produce low-emission hydrogen with significantly lower energy input than electrolysis. These pilots signal a broader role for enzymes in industrial energy transition, pairing selectivity with energy efficiency.
France: Enzymatic Circularity and Flavor Fermentation
France’s hydrolase enzymes industry is advancing through circular plastics and clean-label flavor development. Building on its enzymatic PET recycling breakthrough, Carbios announced additional licensing agreements in 2025 for proprietary PET-hydrolase technology, enabling textile and packaging circularity at industrial scale. In food and beverage, Kerry Group expanded cocoa taste capabilities in Grasse during mid-2025, integrating enzymatic fermentation to enhance natural flavor profiles without chemical additives, aligning with clean-label demand.
Summary Table: Country-Level Strategic Signals in the Hydrolase Enzymes Industry
Hydrolase Enzymes Market County Level Snapshot
|
Country
|
Primary Strategic Driver
|
Core Hydrolase Focus
|
Structural Implication
|
|
Denmark
|
Platform convergence, electrification
|
Lipases, HMOs, biodiesel enzymes
|
Export-ready, low-carbon leadership
|
|
India
|
BioE3 policy, biofoundries
|
Proteases, textile enzymes
|
Scale-up and import substitution
|
|
China
|
Enzymatic mandates, food approvals
|
Proteases, recycling hydrolases
|
Regulatory-led adoption and circularity
|
|
United States
|
R&D expansion, VOC rules
|
Amylases, cellulases
|
Process substitution and SAF enablement
|
|
Germany
|
Food enzyme innovation, pilots
|
Chymosin, industrial hydrolases
|
High-value foods and energy efficiency
|
|
France
|
Enzymatic recycling, fermentation
|
PET hydrolases, flavor enzymes
|
Circularity and clean-label growth
|
Hydrolase Enzymes Market Report Scope
Hydrolase Enzymes Market
|
Parameter
|
Details
|
|
Market Size (2025)
|
$7 Billion
|
|
Market Size (2034)
|
$13.4 Billion
|
|
Market Growth Rate
|
7.5%
|
|
Segments
|
By Type (Esterases, Glycosylases, Peptidases, Other Hydrolases), By Source (Microorganisms, Plant-Based, Animal-Based), By Function (Biocatalysis, Protein Hydrolysis, Starch Conversion, Lipid Modification), By End-Use Industry (Food and Beverages, Pharmaceuticals and Biotechnology, Animal Feed, Detergents and Household Care, Biofuels, Industrial Applications)
|
|
Study Period
|
2019- 2025 and 2026-2034
|
|
Units
|
Revenue (USD)
|
|
Qualitative Analysis
|
Porter’s Five Forces, SWOT Profile, Market Share, Scenario Forecasts, Market Ecosystem, Company Ranking, Market Dynamics, Industry Benchmarking
|
|
Companies
|
Novonesis, International Flavors & Fragrances Inc., dsm-firmenich, BASF SE, Kerry Group plc, Associated British Foods plc, Advanced Enzyme Technologies Ltd., Codexis, Inc., Amano Enzyme Inc., Biocatalysts Ltd., Dyadic International, Inc., Sinopec Catalyst Company, Creative Enzymes, Infinita Biotech Private Limited, Carbios
|
|
Countries
|
US, Canada, Mexico, Germany, France, Spain, Italy, UK, Russia, China, India, Japan, South Korea, Australia, South East Asia, Brazil, Argentina, Middle East, Africa
|
Hydrolase Enzymes Market Segmentation
By Type
- Esterases
- Glycosylases
- Peptidases
- Other Hydrolases
By Source
- Microorganisms
- Plant-Based
- Animal-Based
By Function
- Biocatalysis
- Protein Hydrolysis
- Starch Conversion
- Lipid Modification
By End-Use Industry
- Food and Beverages
- Pharmaceuticals and Biotechnology
- Animal Feed
- Detergents and Household Care
- Biofuels
- Industrial Applications
By Region
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- South and Central America (Brazil, Argentina, Rest of SCA)
- Middle East and Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East, Rest of Africa)
Top Companies in the Hydrolase Enzymes Industry
- Novonesis
- International Flavors & Fragrances Inc.
- dsm-firmenich
- BASF SE
- Kerry Group plc
- Associated British Foods plc
- Advanced Enzyme Technologies Ltd.
- Codexis, Inc.
- Amano Enzyme Inc.
- Biocatalysts Ltd.
- Dyadic International, Inc.
- Sinopec Catalyst Company
- Creative Enzymes
- Infinita Biotech Private Limited
- Carbios
*- List not Exhaustive
